
Academic radiologists usually cut to the chase in describing how imaging increasingly factors into drug discovery and research. They display cellular metabolism FDG-PET images or dynamic-contrast MR images quantifying changes in tumor vascularity. These glamor children of radiological research reflect the potential of medical imaging in measuring therapeutic response.

























